Watch | Business Matters: Why India rejected patent extension for J&J’s TB drug

In this episode of business matters, we discuss why the Indian Patent Office rejected Johnson & Johnson’s application to extend its patent on Bedaquiline, a drug used to treat Tuberculosis.